Dr. Iris Claire Ha, MD

Dr. Ha practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Ha's NPI, 1801244512, was assigned on June 3, 2016. Dr. Ha graduated from University of California, Irvine, School of Medicine in 2015. Dr. Ha's California license number on file is A153330.

Dr. Ha's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Ha's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Ha to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ha practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Ha's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ha is board certified in internal medicine by the American Board of Internal Medicine. Dr. Ha has a license on file in California.

Dmand AI lists acute mini-stroke (TIA), acute skin infection, asthma, atrial fibrillation and flutter, chronic diabetes, chronic hypertension, chronic kidney disease and chronic obstructive pulmonary disease (COPD) among the conditions Dr. Ha treats.

CMS data shows 212 Medicare services from Dr. Ha across 7 procedure codes in 2024, for 103 Medicare patients. Medicare paid $14,678 for them. Every service was in an office.

CMS counts 103 Medicare patients who saw Dr. Ha in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ha's median patient age at 57, with 72% women.

In 2024, Dr. Ha wrote 2,607 Medicare Part D claims for 339 patients. 86% of them were for generic drugs. CMS names the drug for 2,142 of them, across 56 drugs with 11 or more claims each, at $193,702 in total drug cost. In 2023, CMS named 3,154 claims across 69 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Ha for performance year 2024, reported as part of a group. Dr. Ha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ha as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Ha, published from 2011 to 2018. Dr. Ha's most frequent co-authors are Gregory Brennan, MD, Matthew L. Bechtold, MD and Yongyan Cui.

CMS Open Payments shows 9 general payments to Dr. Ha from 6 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $330.

Dr. Ha graduated from University of California, Irvine, School of Medicine in 2015.

Dr. Ha is in network with 6 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.